Advertisement
Screener

BAXTER INTERNATIONAL INC. (BAX) Operating Margin

BAXTER INTERNATIONAL INC. (BAX) Operating Margin

  • Operating margin · 12 months: Value -2.39%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..

Operating margin

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Operating margin · 12 months-2.39%Operating income / revenue. Period ending 2026-06-30.

$-274.00M ÷ $11.47B × 100 ≈ -2.39%

Calculation inputs

InputAmount with unitRaw financial data
Operating income-274.00M USDOperating Income (Loss)
Revenue11.47B USDRevenue from Contract with Customer, Excluding Assessed Tax
Cost of products and services8.02B USDCost of Goods and Services Sold
Research and development512.00M USDResearch and Development Expense
Selling, general and administration2.93B USDSelling, General and Administrative Expense

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingOperating income (USD)Revenue (USD)Cost of products and services (USD)Research and development (USD)Selling, general and administration (USD)Operating margin
2026-06-30$-274.00M$11.47B$8.02B$512.00M$2.93B-2.39%
2026-03-31$-300.00M$11.32B$7.91B$517.00M$2.92B-2.65%
2025-12-31$-308.00M$11.24B$7.87B$518.00M$2.89B-2.74%
2025-09-30$-14.00M$11.02B$7.26B$603.00M$2.89B-0.13%
2025-06-30$-31.00M$10.89B$7.04B$614.00M$2.94B-0.28%
2025-03-31$-43.00M$10.77B$6.89B$610.00M$2.94B-0.40%
2024-12-31$14.00M$10.64B$6.65B$590.00M$2.97B0.13%
2024-09-30$436.00M$15.06B$10.11B$655.00M$3.88B2.89%
2024-06-30$273.00M$15.00B$9.59B$687.00M$4.04B1.82%
2024-03-31$448.00M$14.89B$9.80B$679.00M$3.98B3.01%
2023-12-31$390.00M$14.81B$9.84B$667.00M$3.95B2.63%
2023-09-30$651.00M$15.28B$10.06B$652.00M$3.89B4.26%
2023-06-30$-2.18B$15.18B$10.03B$637.00M$3.83B-14.35%
2023-03-31$-1.92B$15.05B$9.66B$619.00M$3.85B-12.75%
2022-12-31$-1.94B$15.11B$9.72B$605.00M$3.89B-12.86%
2022-09-30$-1.91B$14.74B$9.40B$588.00M$3.86B-12.98%
2022-06-30$1.40B$14.19B$8.66B$565.00M$3.59B9.86%
2022-03-31$1.48B$13.54B$8.24B$556.00M$3.29B10.95%
2021-12-31$1.71B$12.78B$7.68B$534.00M$2.87B13.38%
2021-09-30$1.73B$12.45B$7.56B$531.00M$2.63B13.92%
2021-06-30$1.69B$12.20B$7.43B$525.00M$2.55B13.86%
2021-03-31$1.60B$11.82B$7.25B$503.00M$2.47B13.51%
2020-12-31$1.62B$11.67B$7.09B$521.00M$2.47B13.84%
2020-09-30$1.75B$11.53B$6.84B$542.00M$2.48B15.14%
2020-06-30$1.78B$11.41B$6.68B$563.00M$2.51B15.59%
2020-03-31$1.80B$11.53B$6.68B$612.00M$2.56B15.60%
2019-12-31$1.77B$11.36B$6.60B$595.00M$2.54B15.60%
2019-09-30$1.63B$11.16B$6.51B$614.00M$2.50B14.58%
2019-06-30$1.52B$11.08B$6.41B$636.00M$2.56B13.74%
2019-03-31$1.55B$11.08B$6.33B$644.00M$2.60B14.00%
2018-12-31$1.60B$11.13B$6.35B$655.00M$2.62B14.37%
2018-09-30$1.49B$11.06B$6.31B$661.00M$2.68B13.49%
2018-06-30$1.37B$11.00B$6.36B$649.00M$2.70B12.49%
2018-03-31$1.34B$10.76B$6.23B$630.00M$2.65B12.42%
2017-12-31$1.26B$10.56B$6.10B$617.00M$2.59B11.91%
2017-09-30$1.26B$10.43B$6.03B$592.00M$2.55B12.05%
2017-06-30$1.15B$10.28B$5.94B$600.00M$2.59B11.19%
2017-03-31$880.00M$10.26B$6.08B$639.00M$2.67B8.57%
2016-12-31$724.00M$10.16B$6.05B$647.00M$2.74B7.12%
2016-09-30$620.00M$10.12B$6.04B$651.00M$2.81B6.13%
2016-06-30$526.00M$10.05B$6.01B$640.00M$2.88B5.23%
2016-03-31$545.00M$9.94B$5.85B$596.00M$2.95B5.48%
2015-12-31$449.00M$9.97B$5.82B$603.00M$3.09B4.50%
2015-09-30(m)$16.11B$8.25B$1.41B$3.94B(m)
2015-06-30(m)$16.33B$8.31B$1.48B$4.24B(m)
2015-03-31(m)$16.59B$8.52B$1.41B$4.13B(m)
2014-12-31(m)$16.67B$8.51B$1.42B$4.03B(m)
2014-09-30(m)$16.81B$8.76B$1.56B$4.03B(m)
2014-06-30(m)$16.36B$8.46B$1.36B$3.97B(m)
2014-03-31(m)$15.76B$7.96B$1.31B$3.81B(m)
2013-12-31(m)$15.26B$7.66B$1.25B$3.68B(m)
2013-09-30(m)$14.64B$7.10B$1.10B$3.66B(m)
2013-06-30(m)$14.35B$6.94B$1.10B$3.42B(m)
2013-03-31(m)$14.25B$6.91B$1.13B$3.37B(m)
2012-12-31(m)$14.19B$6.89B$1.16B$3.32B(m)
2012-09-30(m)$14.03B$6.87B$1.12B$3.17B(m)
2012-06-30(m)$14.03B$6.91B$1.07B$3.21B(m)
2012-03-31(m)$14.00B$6.91B$1.00B$3.19B(m)
2011-12-31(m)$13.89B$6.85B$946.00M$3.15B(m)
2011-09-30(m)$13.80B$6.90B$954.00M$3.10B(m)
2011-06-30(m)$13.54B$6.75B$922.00M$2.98B(m)
2011-03-31(m)$13.20B$6.61B$902.00M$2.94B(m)
2010-12-31(m)$12.84B$6.88B$915.00M$2.91B(m)
2010-09-30(m)$12.81B$6.71B$899.00M$2.86B(m)
2010-06-30(m)$12.74B$6.66B$920.00M$2.86B(m)
2010-03-31(m)$12.66B$6.58B$932.00M$2.80B(m)
2009-12-31(m)$12.56B$6.04B$917.00M$2.73B(m)
2009-09-30(m)(m)(m)(m)(m)(m)
2009-06-30(m)(m)(m)(m)(m)(m)
2009-03-31(m)(m)(m)(m)(m)(m)
2008-12-31(m)$12.35B$6.22B$868.00M$2.70B(m)
2008-09-30(m)(m)(m)(m)(m)(m)
2008-06-30(m)(m)(m)(m)(m)(m)
2007-12-31(m)$11.26B$5.74B$760.00M$2.52B(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Penumbra Inc (PEN)United States$12.596B77.33
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
Solventum Corp (SOLV)United States$15.085B9.16
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B